Company Tiger X Medical Inc Other OTC
Equities
US88677A1043
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -64.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -64.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter Altman
CEO | Chief Executive Officer | 57 | 01/02/01 |
David McClung
DFI | Director of Finance/CFO | 61 | 01/13/01 |
Chief Tech/Sci/R&D Officer | - | 01/17/01 | |
Sujith Shetty
CTO | Chief Tech/Sci/R&D Officer | - | 01/19/01 |
Ian McNiece
CTO | Chief Tech/Sci/R&D Officer | 70 | 08/17/08 |
Anne Laluc
IRO | Public Communications Contact | - | - |
Mark Schwartz
PRN | Corporate Officer/Principal | - | 01/18/01 |
Edward Gillis
PRN | Corporate Officer/Principal | 62 | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Stertzer
BRD | Director/Board Member | 88 | 01/02/01 |
Jay Moyes
BRD | Director/Board Member | 70 | 01/11/01 |
Richard Krasno
BRD | Director/Board Member | 82 | 24/16/24 |
Director/Board Member | 53 | 18/23/18 | |
Peter Altman
CEO | Chief Executive Officer | 57 | 01/02/01 |
Andrew Blank
CHM | Chairman | 68 | 01/19/01 |
Jim Allen
BRD | Director/Board Member | 69 | 01/19/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,304,116 | 19,255,345 ( 70.52 %) | 0 | 70.52 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- BCDA Stock
- Stock
- Company Tiger X Medical Inc